$24.01−0.32 (−1.32%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Veracyte (VCYT) Institutional Ownership
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
5 figures withheld by our checks. Each blank figure names its reason.
13F fund flowQuarter ended Jun 30, 2026*. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 375 filers, Jun 30, 2026
# 13F FUNDS
375
13F VALUE
$5.2B
89.4M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Disposed · Tax withholding | 1,306 | $50.31 | ↗ |
| Oct 27, 2026 | Holstein Jens | director | Acquired · Option exercise | 7,500 | $35.30 | ↗ |
| Oct 27, 2026 | Holstein Jens | director | Disposed · Open-market sale | 7,500 | $50.00 | ↗ |
| Oct 27, 2026 | Holstein Jens | director | Disposed · Option exercise | 7,500Stock Option (right to buy) | — | ↗ |
| Oct 27, 2026 | EASTHAM KARIN | director | Acquired · Option exercise | 10,000 | $27.01 | ↗ |
| Oct 27, 2026 | EASTHAM KARIN | director | Disposed · Open-market sale | 14,850 | $50.00 | ↗ |
| Oct 27, 2026 | EASTHAM KARIN | director | Disposed · Option exercise | 10,000Stock Option (right to buy) | — | ↗ |
| Oct 19, 2026 | Bhanji Muna | director | Disposed · Open-market sale | 1,864 | $43.70 | ↗ |
| Sep 24, 2026 | Holstein Jens | director | Acquired · Option exercise | 7,500 | $35.30 | ↗ |
| Sep 24, 2026 | Holstein Jens | director | Disposed · Open-market sale | 7,500 | $47.00 | ↗ |
| Sep 24, 2026 | Holstein Jens | director | Disposed · Option exercise | 7,500Stock Option (right to buy) | — | ↗ |
| Sep 21, 2026 | Leite John | Global Chief Commercial Off | Disposed · Open-market sale | 4,015 | $40.00 | ↗ |
| Sep 14, 2026 | Holstein Jens | director | Disposed · Open-market sale | 5,000 | $40.95 | ↗ |
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Disposed · Open-market sale | 2,154 | $42.79 | ↗ |
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Disposed · Open-market sale | 1,100 | $43.67 | ↗ |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Disposed · Open-market sale | 2,477 | $42.81 | ↗ |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Disposed · Open-market sale | 1,175 | $43.71 | ↗ |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Disposed · Open-market sale | 10,405 | $42.89 | ↗ |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Disposed · Open-market sale | 2,705 | $43.66 | ↗ |
| Sep 2, 2026 | Leite John | Global Chief Commercial Off | Disposed · Tax withholding | 3,961 | $44.88 | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How many 13F filers hold Veracyte?
Veracyte was held by 375 13F filers as of Jun 30, 2026.
Not investment advice.

